Mereo BioPharma Group plc (MREO) Income Annual - Discounting Cash Flows
MREO
Mereo BioPharma Group plc
MREO (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing 2025-05-13 2025-03-26 2024-03-27 2023-03-28 2022-03-31 2021-03-31 2020-06-15 2019-04-29 2017-12-31 2016-12-31
Revenue 0 0 10 1.51 36.46 0.393 -0.122 0 -3.29 0
Cost of Revenue 0.257 0 2.57 0.936 17.91 16.35 23.61 22.7 34.61 24.56
Gross Profit -0.257 0 7.43 0.571 18.56 -15.95 -23.73 -22.7 -37.89 -24.56
Operating Expenses 48.41 47.36 35.84 44.14 39.49 21.61 15.79 12.5 7.41 11.62
Research & Development 20.87 20.94 17.42 24.96 23.56 -16.35 -23.61 22.7 34.61 24.56
Selling, General and Administrative 27.8 26.43 18.42 19.54 15.93 21.22 15.91 12.5 10.7 11.62
Other Operating Expenses -0.257 -0.009 0 -0.365 0 16.74 23.49 -22.7 -37.89 -24.56
Operating Income -48.66 -47.36 -28.42 -43.57 -20.94 -37.57 -39.52 -35.21 -45.3 -36.18
Net Non-Operating Interest 2.2 1.67 -0.75 -2.67 -4 -6.34 -3.12 -2.05 -0.263 0.015
Interest Income 3.08 3.04 2.13 0.696 0.001 0.044 0.377 0.307 0.827 0.195
Interest Expense 0.879 1.37 2.88 3.36 4 6.38 3.5 2.36 1.09 0.18
Equity & Other Income/(Expense) -0.728 2.44 -0.832 10.14 39.18 -122.5 1.52 -0.044 -1.38 2.44
Income Before Tax -47.19 -43.25 -30 -36.09 14.24 -166.4 -41.12 -37.31 -46.95 -33.72
Income Tax Expense 0 0.018 -0.532 -1.9 1.52 -2.82 -6.27 -5.28 -8.15 -5.33
Income Attributable to Non-Controlling Interest 0 -0.018 0 0 0 0 0 0 0 0
Net Income -47.19 -43.25 -29.47 -34.2 12.72 -163.6 -34.84 -32.03 -38.8 -28.39
Depreciation and Amortization 0.813 0 1.06 1.51 0.866 0.044 1.95 0.038 0.036 0.033
EBITDA -47.85 -47.36 -27.36 -42.06 -20.07 -37.52 -37.56 -35.17 -45.27 -36.15
Earnings Per Share (EPS) -930.8 -0.29 -1,100 -1,750 749.6 -16,503 -12,903 -14,353 -19,004 -19,554
Diluted Earnings Per Share -930.8 -0.29 -1,100 -1,750 749.6 -16,503 -12,903 -14,353 -19,004 -19,554
Weighted Average Shares Outstanding 156.9 147.9 131.9 120.6 116.7 67.79 17.87 14.23 13.8 8.96
Diluted Weighted Average Shares Outstanding 156.9 147.9 131.9 120.6 116.7 67.79 17.88 14.23 13.8 8.96
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us